Form 4: Notable Labs Director Acquires Shares Through Restricted Stock Grant
SEC Form 4 Filing
Director Tuomo Patsi acquired 65,247 ordinary shares of Notable Labs, Ltd. through a restricted stock grant on May 8, 2024.
Summary
- On May 8, 2024, Tuomo Patsi, a director of Notable Labs, Ltd., acquired 65,247 ordinary shares of the company.
- The acquisition was a result of a restricted stock grant.
- The shares vest in two equal annual installments from the date of the grant.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard transaction filing, and the acquisition of shares by a director can be seen as a slightly positive sign.
Positives
- The acquisition of shares by a director could be seen as a positive sign, indicating confidence in the company's future.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Stakeholder Impact
- The acquisition of shares by a director may increase investor confidence.
Key Dates
| Date | Description |
|---|---|
| 05/08/2024 | Date of transaction: Tuomo Patsi acquired 65,247 ordinary shares through a restricted stock grant. |
| 05/10/2024 | Date of signature on the SEC Form 4 filing. |
Keywords
Notable Labs, Tuomo Patsi, Director, Share Acquisition, Restricted Stock, NTBL
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.